Right before everyone started shutting down for Thanksgiving, the folks at Politico who track the “influence” industry in Washington, DC ran an interesting item about the pharmaceutical industry. Specifically, it relates to how much money the industry ran through various independent-sounding groups to try to shut down Medicare drug price negotiation– about the only component of the so-called “Inflation Reduction Act” that actually involved government spending less money, but also a policy whose GOP version under Trump was (not surprisingly) a lot more appealing to 50 percent of the country. Read More
Big Pharma Spending Big Bucks to Keep the Government on Their Side – At Your Expense
